Documentation
As a legal entity associated with the third sector, the association is required to possess and publish certain documents of public interest. Below, you can consult our bylaws, transparency statements, 5x1000 reports, and abstracts from some of the funded projects.
Transparency Statements
Social promotion associations and volunteer organizations registered in the regional registers as per L.R. 27/2001, article 43, and L.R. 40/93, article 4, that receive public funding or have agreements with the public administration, are obligated, in accordance with article 52 of Regional Law No. 30 of December 30, 2016, to annually disclose the amount of public funds they have received. Following this requirement, the public funds received by our association are as follows:
> 2021: Dichiarazione 2021 (Art.52L.R.30:2016) / Dichiarazione 2021 (Legge124-2017)
> 2020: Dichiarazione 2020 (Legge124-2017) / Dichiarazioone 2020 (Art.52L.R.30:2016)
> 2019: Dichiarazione 2019 (Art.52L.R.30:2016) / Dichiarazione 2019 (Legge124-2017)
> 2018: Dichiarazione 2018 (Art.52L.R.30:2016) / Dichiarazione 2018 (Legge124-2017)
> 2017: Dichiarazione 2017 (Art.52 L.R.30:2016) / Dichiarazione 2017 (Legge124-2017)
Funded Projects
Over the years, the association has had the opportunity to financially support, and not only, various research projects by allocating funds mainly in Italy, the United States, and Spain. In addition to these, we have consistently provided support for clinical trials involving patients. Following are excerpts from some of the projects we have sponsored:
> 2022: PRE-RECEPTOR IGM-CNR Bologna
> 2021: POLIFARM IGM-CNR Bologna / PRF Workshop PRF Boston / TARGETS IGM-CNR Bologna
> 2020: HGPS-TISSUES IGM-CNR Bologna
> 2019: CYTO-HGPS IGM-CNR Bologna / Clinical Trial Everolimus PRF Boston
> 2018: TREAT-HGPS-ITALY IGM-CNR Bologna
> 2017: HGPS CRISPR-Cas9 UniOvi Oviedo / TREAT-HGPS IGM-CNR Bologna
> 2016: IL6-HGPS IGM-CNR Bologna
> 2015: ANTI-PROGERIN MIX IGM-CNR Bologna
